Results 1 to 10 of about 27,651 (149)

Differences in the Prognostic Value of Tumor Extent of Resection among the Molecular Subgroups of Medulloblastoma: A Single Centre Study of 113 Cases

open access: yesBrain Science Advances, 2017
Medulloblastoma (MB) is one of the most common pediatrics malignant tumors of the central nervous system. Studies in America and Europe have demonstrated significant differences in the prognostic value of medulloblastoma extent among molecular subgroups ...
Yuyuan Wang   +8 more
doaj   +1 more source

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. [PDF]

open access: yes, 2019
Accelerating cures for children with cancer remains an immediate challenge as a result of extensive oncogenic heterogeneity between and within histologies, distinct molecular mechanisms evolving between diagnosis and relapsed disease, and limited ...
Baxter, Patricia   +68 more
core  

Levy model of cancer

open access: yes, 2020
A small portion of a tissue defines a microstate in gene expression space. Mutations, epigenetic events or external factors cause microstate displacements which are modeled by combining small independent gene expression variations and large Levy jumps ...
Gonzalez, Augusto   +2 more
core  

DNA methylation-based classification of central nervous system tumours. [PDF]

open access: yes, 2018
Accurate pathological diagnosis is crucial for optimal management of patients with cancer. For the approximately 100 known tumour types of the central nervous system, standardization of the diagnostic process has been shown to be particularly challenging-
Aronica, Eleonora   +99 more
core   +1 more source

Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma

open access: yesGenome Medicine
Background The current standard of care treatments for medulloblastoma are insufficient as these do not take tumor heterogeneity into account. Newer, safer, patient-specific treatment approaches are required to treat high-risk medulloblastoma patients ...
Changlin Yang   +6 more
doaj   +1 more source

Targeting protein synthesis pathways in MYC-amplified medulloblastoma

open access: yesDiscover Oncology
MYC is one of the most deregulated oncogenic transcription factors in human cancers. MYC amplification/or overexpression is most common in Group 3 medulloblastoma and is positively associated with poor prognosis.
Devendra Kumar   +2 more
doaj   +1 more source

Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis

open access: yesCurrent Oncology
Medulloblastoma, a malignant pediatric brain tumor, has a poor prognosis upon relapse, highlighting a critical clinical need. Our previous research linked medulloblastoma cell radioresistance to integrin-αvβ3 expression.
Célia Gotorbe   +15 more
doaj   +1 more source

Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors [PDF]

open access: yes, 2017
Dearborn, Joshua   +8 more
core   +2 more sources

Congenital medulloblastoma [PDF]

open access: yesArchives of Disease in Childhood - Fetal and Neonatal Edition, 2006
B, Ermis   +5 more
openaire   +3 more sources

Multifocal medulloblastoma in an adult: a case report and review of the literature

open access: yesJournal of Cancer Research and Clinical Oncology
Background Medulloblastoma (MB) is a highly aggressive tumor originating in the cerebellum, predominantly affecting children. Adult medulloblastoma is rare, leading to a lack of a standardized treatment protocol.
Cha Luo   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy